O'Riordan files Form 144 to sell 14,687 Jazz Pharmaceuticals shares
Director Anne O'Riordan registered a Form 144 indicating restricted shares of Jazz Pharmaceuticals (JAZZ) totaling 14,687 for sale, with the registration dated 10/8/2026 and the approximate sale date also 10/8/2026.